Evidence map›Paper›PMID 34620830›Full record

ArticleTranslational psychiatry2021

Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium.

Nooshin Javaheripour, Meng Li, Tara Chand, Axel Krug, Tilo Kircher, Udo Dannlowski, Igor Nenadić, J Paul Hamilton, Matthew D Sacchet, Ian H Gotlib and 22 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 2 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. FUNCTIONAL CONNECTIVITY ALTERATIONS IN MAJOR DEPRESSIVE DISORDER.bioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 7 countries.

Nooshin JavaheripourDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
Meng LiDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
Tara ChandDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
Axel KrugDepartment of Psychiatry and Psychotherapy, University of Bonn, 53127, Bonn, Germany.ORCID http://orcid.org/0000-0002-0564-2497
Tilo KircherDepartment of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Udo DannlowskiInstitute for Translational Psychiatry, University of Münster, 48149, Münster, Germany.
Igor NenadićDepartment of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
J Paul HamiltonCenter for Social and Affective Neuroscience, Center for Medical Image Science and Visualization, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0001-7982-4659
Matthew D SacchetCenter for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.
Ian H GotlibDepartment of Psychology, Stanford University, Bldg. 420, Jordan Hall, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0002-3622-3199
Henrik WalterDepartment of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-9403-6121
Thomas FrodlDepartment of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Leipzigerstr. 44, 39120, Magdeburg, Germany.ORCID http://orcid.org/0000-0002-8113-6959
Simone GrimmDepartment of Psychiatry and Psychotherapy, CBF, Charité Universitätsmedizin Berlin, 12203, Berlin, Germany.
Ben J HarrisonMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Victoria, Australia.
Christian Robert WolfCenter for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany.
Sebastian OlbrichDepartment of Psychiatry, Psychotherapy and Psychosomatic, University Zürich, Zürich, Switzerland.
Guido van WingenDepartment of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3076-5891
Lukas PezawasDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-1329-6352
Gordon ParkerSchool of Psychiatry, AGSM Building, University of New South Wales, Sydney, Australia.
Matthew P HyettSchool of Psychological Sciences, University of Western Australia, Perth, Australia.
Philipp G SämannMax Planck Institute of Psychiatry, Munich, Germany.
Tim HahnInstitute for Translational Psychiatry, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-6541-3795
Olaf SteinsträterDepartment of Psychiatry and Psychotherapy, Philipps Universität Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Andreas JansenDepartment of Psychiatry and Psychotherapy & Marburg Center for Mind, Brain and Behavior - MCMBB, Philipps- Universität Marburg, Marburg, Germany.
Dilara YukselCenter for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA, USA.
Robin KämpeCenter for Social and Affective Neuroscience, Center for Medical Image Science and Visualization, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Christopher G DaveyDepartment of Psychiatry, The University of Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-1431-3852
Bernhard MeyerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
Lucie BartovaDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-1769-8025
Ilona CroyDepartment of Psychology, Friedrich Schiller University Jena, Jena, Germany.
Martin Walter *Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.
Gerd Wagner *Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany. wagner.gerd@uni-jena.de.ORCID http://orcid.org/0000-0003-2296-0259
Jena University Hospital · DEPhilipps University of Marburg · DEMedical University of Vienna · ATLinköping University · SEThe University of Melbourne · AUUniversity of Münster · DEAmsterdam Neuroscience · NLCharité - Universitätsmedizin Berlin · DEFriedrich Schiller University Jena · DEHarvard University · USHeidelberg University · DEHumboldt-Universität zu Berlin · DEMax Planck Institute of Psychiatry · DEOtto-von-Guericke-Universität Magdeburg · DESRI International · USStanford University · USThe University of Western Australia · AUUniversity of Bonn · DEUniversity of Zurich · CHUNSW Sydney · AU

Funding

Austrian Science Fund FWF KLI 597
6 · The paper itself

Abstract

Major depressive disorder (MDD) is associated with abnormal neural circuitry. It can be measured by assessing functional connectivity (FC) at resting-state functional MRI, that may help identifying neural markers of MDD and provide further efficient diagnosis and monitor treatment outcomes. The main aim of the present study is to investigate, in an unbiased way, functional alterations in patients with MDD using a large multi-center dataset from the PsyMRI consortium including 1546 participants from 19 centers ( www.psymri.com ). After applying strict exclusion criteria, the final sample consisted of 606 MDD patients (age: 35.8 ± 11.9 y.o.; females: 60.7%) and 476 healthy participants (age: 33.3 ± 11.0 y.o.; females: 56.7%). We found significant relative hypoconnectivity within somatosensory motor (SMN), salience (SN) networks and between SMN, SN, dorsal attention (DAN), and visual (VN) networks in MDD patients. No significant differences were detected within the default mode (DMN) and frontoparietal networks (FPN). In addition, alterations in network organization were observed in terms of significantly lower network segregation of SMN in MDD patients. Although medicated patients showed significantly lower FC within DMN, FPN, and SN than unmedicated patients, there were no differences between medicated and unmedicated groups in terms of network organization in SMN. We conclude that the network organization of cortical networks, involved in processing of sensory information, might be a more stable neuroimaging marker for MDD than previously assumed alterations in higher-order neural networks like DMN and FPN.

Indexed as

ConnectomeMajor Depressive DisorderAdultBrainBrain MappingFemaleHumansMagnetic Resonance ImagingMiddle AgedNeural PathwaysRestYoung Adult

Identifiers

PMID34620830
PMCPMC8497531
OpenAlexW3202102142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.